The Procter & Gamble Company (PG) 10-Q 20 Apr 22 2022 Q3 Quarterly report Financial data

DOCUMENT AND ENTITY INFORMATION

DOCUMENT AND ENTITY INFORMATION	9 Months Ended
	Mar. 31, 2022shares
Entity Information [Line Items]
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding	2,399,296,841
Entity Emerging Growth Company	false
Entity Central Index Key	0000080424
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Incorporation, State or Country Code	OH
Entity File Number	1-434
Entity Tax Identification Number	31-0411980
Entity Address, Address Line One	One Procter & Gamble Plaza
Entity Address, City or Town	Cincinnati
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	45202
City Area Code	513
Local Phone Number	983-1100
Document Transition Report	false
Document Quarterly Report	true
Document Type	10-Q
Document Period End Date	Mar. 31, 2022
Entity Registrant Name	PROCTER & GAMBLE CO
Entity Small Business	false
Entity Interactive Data Current	Yes
Entity Current Reporting Status	Yes
Entity Shell Company	false
Common Stock [Member]
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, without Par Value
Trading Symbol	PG
2.000% due 2022 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	2.000% Notes due 2022
Trading Symbol	PG22B
1.125% due 2023 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	1.125% Notes due 2023
Trading Symbol	PG23A
0.500% due 2024 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	0.500% Notes due 2024
Trading Symbol	PG24A
0.625% due 2024 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	0.625% Notes due 2024
Trading Symbol	PG24B
1.375% due 2025 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	1.375% Notes due 2025
Trading Symbol	PG25
0.110 due 2026 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	0.110% Notes due 2026
Trading Symbol	PG26D
4.875% EUR due May 2027 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	4.875% EUR notes due May 2027
Trading Symbol	PG27A
1.200% due 2028 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	1.200% Notes due 2028
Trading Symbol	PG28
1.250% due 2029 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	1.250% Notes due 2029
Trading Symbol	PG29B
1.800% due 2029 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	1.800% Notes due 2029
Trading Symbol	PG29A
6.250% GBP due January 2030 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	6.250% GBP notes due January 2030
Trading Symbol	PG30
0.350% due 2030 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	0.350% Notes due 2030
Trading Symbol	PG30C
0.230% due 2031 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	0.230% Notes due 2031
Trading Symbol	PG31A
5.250% GBP due January 2033 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	5.250% GBP notes due January 2033
Trading Symbol	PG33
1.875% due 2038 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	1.875% Notes due 2038
Trading Symbol	PG38
0.900% due 2041 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	0.900% Notes due 2041
Trading Symbol	PG41
NEW YORK STOCK EXCHANGE, INC. [Member]
Entity Information [Line Items]
Security Exchange Name	NYSE
NEW YORK STOCK EXCHANGE, INC. [Member] | Common Stock [Member]
Entity Information [Line Items]
Security Exchange Name	NYSE

CONSOLIDATED STATEMENTS OF EARN

CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) shares in Millions, $ in Millions		3 Months Ended		9 Months Ended
		Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Net Sales		$ 19,381	$ 18,109	$ 60,672	$ 57,172
Cost of Products Sold		10,326	8,922	31,355	27,317
Selling, General and Administrative Expense		5,031	5,402	15,102	15,409
Operating Income		4,024	3,785	14,215	14,446
Interest Expense		(109)	(106)	(324)	(385)
Interest Income		9	11	30	30
Other Non-operating Income/(Loss), Net		147	187	424	(40)
Earnings/(Loss) from Continuing Operations Before Income Taxes		4,071	3,877	14,345	14,051
Income Taxes on Continuing Operations		704	628	2,610	2,607
Net Earnings		3,367	3,249	11,735	11,444
Net Income (Loss) Attributable to Noncontrolling Interest		12	(20)	45	44
Net Income (Loss) Attributable to Parent		$ 3,355	$ 3,269	$ 11,690	$ 11,400
Basic Net Earnings Per Common Share
Basic Net Earnings/(Loss) Per Common Share	[1],[2]	$ 1.37	$ 1.30	$ 4.76	$ 4.53
Diluted Net Earnings Per Common Share
Diluted Net Earnings/(Loss) Per Common Share	[1],[2]	$ 1.33	$ 1.26	$ 4.59	$ 4.37
Diluted Weighted Average Common Shares Outstanding		2,530.2	2,590.3	2,544.4	2,610.4
[1]	Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
[2]	Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

CONDOLIDATED STATEMENTS OF COMP

CONDOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Net Earnings	$ 3,367	$ 3,249	$ 11,735	$ 11,444
Foreign Currency Translation	23	(598)	(683)	639
Unrealized Gains/(Losses) on Investment Securities	0	5	7	19
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax	89	194	968	24
Total Other Comprehensive Income (Loss), Net of Tax	112	(399)	292	682
Total Comprehensive Income/(Loss)	3,479	2,850	12,027	12,126
Less: Total Comprehensive Income Attributable to Noncontrolling Interest	8	(21)	41	50
Total Comprehensive Income/(Loss) Attributable to Procter & Gamble	$ 3,471	$ 2,871	$ 11,986	$ 12,076

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) shares in Millions, $ in Millions	Mar. 31, 2022	Jun. 30, 2021
Current Assets
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 8,526	$ 10,288
Accounts Receivable	5,513	4,725
Inventories
Materials and Supplies	2,146	1,645
Work in Process	837	719
Finished Goods	4,118	3,619
Total Inventories	7,101	5,983
Prepaid Expenses and Other Current Assets	2,276	2,095
Total Current Assets	23,416	23,091
Property, Plant and Equipment, Net	21,323	21,686
Goodwill	40,710	40,924
Trademarks and Other Intangible Assets, Net	23,913	23,642
Other Noncurrent Assets	10,855	9,964
Total Assets	120,217	119,307
Current Liabilities
Accounts Payable	14,175	13,720
Accrued and Other Liabilities	10,324	10,523
Debt Due Within One Year	9,902	8,889
Total Current Liabilities	34,401	33,132
Long-Term Debt	23,767	23,099
Deferred Income Tax Liabilities, Net	6,543	6,153
Other Noncurrent Liabilities	9,760	10,269
Total Liabilities	74,471	72,653
Shareholders' Equity
Preferred Stock	$ 846	$ 870
Common Stock, Shares, Issued	4,009.2	4,009.2
Common Stock, Value, Issued	$ 4,009	$ 4,009
Additional Paid in Capital	65,614	64,848
Reserve For ESOP Debt Retirement	(916)	(1,006)
Accumulated Other Comprehensive Income/(Loss)	(13,448)	(13,744)
Treasury Stock	(122,272)	(114,973)
Retained Earnings	111,645	106,374
Noncontrolling Interest	268	276
Total Shareholders' Equity	45,746	46,654
Total Liabilities and Shareholders' Equity	$ 120,217	$ 119,307

CONSOLIDATED STATEMENTS OF SHAR

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Millions	Total	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Reserve for ESOP Debt Retirement [Member]	AOCI Attributable to Parent [Member]	Treasury Stock [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]
Common Stock, Shares, Outstanding, Beginning Balance at Jun. 30, 2020		2,479,746
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Jun. 30, 2020	$ 46,878	$ 4,009	$ 897	$ 64,194	$ (1,080)	$ (16,165)	$ (105,573)	$ 100,239	$ 357
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Earnings	11,444							11,400	44
Other Comprehensive Income (Loss), Net of Tax	$ 682					676			6
Common Stock, Dividends, Per Share, Cash Paid	$ 2.3721
Dividends, Common Stock	$ (5,887)							(5,887)
Dividends, Preferred Stock	(197)							(197)
Stock Repurchased During Period, Shares		(59,212)
Stock Repurchased During Period, Value	(8,009)						(8,009)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		24,945
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	1,899			484			1,415
Stock Issued During Period, Shares, Conversion of Convertible Securities		2,754
Stock Issued During Period, Value, Conversion of Convertible Securities	0		(24)	(4)			(20)
ESOP Debt Impacts	193				74			119
Noncontrolling Interest, Period Increase (Decrease)	(84)								(84)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2021		2,448,233
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2021	46,919	$ 4,009	873	64,682	(1,006)	(15,489)	(112,147)	105,674	323
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2020		2,462,476
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2020	48,540	$ 4,009	885	64,672	(1,072)	(15,091)	(109,583)	104,361	359
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Earnings	3,249							3,269	(20)
Other Comprehensive Income (Loss), Net of Tax	$ (399)					(398)			(1)
Common Stock, Dividends, Per Share, Cash Paid	$ 0.7907
Dividends, Common Stock	$ (1,952)							(1,952)
Dividends, Preferred Stock	(65)							(65)
Stock Repurchased During Period, Shares		(23,085)
Stock Repurchased During Period, Value	(3,001)						(3,001)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		7,605
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	435			8			427
Stock Issued During Period, Shares, Conversion of Convertible Securities		1,237
Stock Issued During Period, Value, Conversion of Convertible Securities	0		(12)	(2)			(10)
ESOP Debt Impacts	127				66			61
Noncontrolling Interest, Period Increase (Decrease)	(15)								(15)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2021		2,448,233
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2021	46,919	$ 4,009	873	64,682	(1,006)	(15,489)	(112,147)	105,674	323
Common Stock, Shares, Outstanding, Beginning Balance at Jun. 30, 2021		2,429,706
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Jun. 30, 2021	46,654	$ 4,009	870	64,848	(1,006)	(13,744)	(114,973)	106,374	276
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Earnings	11,735							11,690	45
Other Comprehensive Income (Loss), Net of Tax	$ 292					296			(4)
Common Stock, Dividends, Per Share, Cash Paid	$ 2.6094
Dividends, Common Stock	$ (6,318)							(6,318)
Dividends, Preferred Stock	(208)							(208)
Stock Repurchased During Period, Shares		(58,695)
Stock Repurchased During Period, Value	(8,753)						(8,753)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		25,531
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	2,198			764			1,434
Stock Issued During Period, Shares, Conversion of Convertible Securities		2,755
Stock Issued During Period, Value, Conversion of Convertible Securities	0		(24)	(4)			(20)
ESOP Debt Impacts	197				90			107
Noncontrolling Interest, Period Increase (Decrease)	(51)			(2)					(49)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2022		2,399,297
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2022	45,746	$ 4,009	846	65,614	(916)	(13,448)	(122,272)	111,645	268
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2021		2,397,066
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2021	44,893	$ 4,009	856	65,432	(965)	(13,564)	(121,543)	110,393	275
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Earnings	3,367							3,355	12
Other Comprehensive Income (Loss), Net of Tax	$ 112					116			(4)
Common Stock, Dividends, Per Share, Cash Paid	$ 0.8698
Dividends, Common Stock	$ (2,092)							(2,092)
Dividends, Preferred Stock	(68)							(68)
Stock Repurchased During Period, Shares		(7,909)
Stock Repurchased During Period, Value	(1,249)						(1,249)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		9,108
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	692			180			512
Stock Issued During Period, Shares, Conversion of Convertible Securities		1,032
Stock Issued During Period, Value, Conversion of Convertible Securities	0		(10)	(2)			(8)
ESOP Debt Impacts	106				49			57
Noncontrolling Interest, Period Increase (Decrease)	(15)			0					(15)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2022		2,399,297
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2022	$ 45,746	$ 4,009	$ 846	$ 65,614	$ (916)	$ (13,448)	$ (122,272)	$ 111,645	$ 268

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions		9 Months Ended
		Mar. 31, 2022	Mar. 31, 2021
Statement of Cash Flows [Abstract]
Cash, Cash Equivalent and Restricted Cash Beginning of Period		$ 10,288	$ 16,181
Operating Activities
Net Earnings		11,735	11,444
Depreciation and Amortization		2,085	2,025
Gain (Loss) on Extinguishment of Debt		0	512
Share-based Compensation Expense		398	398
Deferred Income Taxes		(259)	(167)
Gain (Loss) on Disposition of Assets		(84)	(15)
Changes In:
Accounts Receivable		(916)	(604)
Inventories		(1,252)	(399)
Accounts Payable, Accrued and Other Liabilities		1,347	1,049
Other Operating Assets and Liabilities		(131)	(92)
Other Noncash Expense		87	99
Total Operating Activities		13,010	14,250
Investing Activities
Payments to Acquire Property, Plant, and Equipment		(2,464)	(2,073)
Proceeds from Asset Sales		99	40
Payments for (Proceeds from) Businesses and Interest in Affiliates		(1,381)	0
Payments for (Proceeds from) Investments		4	(10)
Total Investing Activites		(3,742)	(2,043)
Financing Activities
Dividends to Shareholders		(6,508)	(6,066)
Proceeds from Short-term Debt, Maturing in More than Three Months		10,146	6,238
Repayments of Short-term Debt, Maturing in More than Three Months		(8,163)	(3,805)
Change in Short-term Debt		(849)	(5,814)
Proceeds from Issuance of Debt		4,385	2,429
Repayments of Long-term Debt	[1]	(2,776)	(4,889)
Treasury Stock Purchases		(8,753)	(8,009)
Impact of Stock Options and Other		1,800	1,470
Total Financing Activities		(10,718)	(18,446)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents		(312)	65
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total		(1,762)	(6,174)
Cash, Cash Equivalents and Restricted Cash, End of Period		$ 8,526	$ 10,007
[1]	Includes early extinguishment of debt costs of $512 during the nine months ended March 31, 2021.

BASIS OF PRESENTATION

BASIS OF PRESENTATION	9 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Basis of PresentationThese statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021. In the opinion of management, the accompanying unaudited Consolidated Financial Statements of The Procter & Gamble Company and subsidiaries (the "Company," "Procter & Gamble," "P&G," "we" or "our") contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, the results of operations included in such financial statements may not necessarily be indicative of annual results. Beginning in fiscal year 2022, the Company began to present increases and reductions in short-term debt with maturities of more than three months separately within the Consolidated Statements of Cash Flows. The presentation for the nine months ended March 31, 2021 has been revised to align with the current period presentation. This change had no impact on total financing activities, and we have concluded the change is not material.

NEW ACCOUNTING PRONOUNCEMENTS A

NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES	9 Months Ended
	Mar. 31, 2022
Accounting Changes and Error Corrections [Abstract]
Accounting Standards Update and Change in Accounting Principle	New Accounting Pronouncements and Policies In March 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting". The amendments provide optional expedients and exceptions for applying generally accepted accounting principles ("GAAP") to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. In January 2021, the FASB issued ASU No. 2021-01, "Reference Rate Reform (Topic 848): Scope", which clarified that certain optional expedients and exceptions in Topic 848 apply to derivative instruments that are affected by the discounting transition due to reference rate reform. These ASUs were effective upon issuance and may be applied prospectively to contract modifications and hedging relationships entered into or evaluated through December 31, 2022. We have completed our evaluation of significant contracts. Most contracts reviewed will mature prior to the termination of LIBOR or will be modified to apply a new reference rate, primarily the Secured Overnight Financing Rate ("SOFR") where applicable. As a result, the guidance has not had, and is not expected to have, a material impact on the Company's Consolidated Financial Statements. In November 2021, the FASB issued ASU 2021-10, "Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance". This guidance requires annual disclosures for transactions with a government authority that are accounted for by applying a grant or contribution model. These amendments are effective for annual periods beginning after December 15, 2021, with early adoption permitted. We plan to adopt the standard for the fiscal year ending June 30, 2023. We are currently assessing the impact of this guidance on our Consolidated Financial Statements and disclosures. No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.

SEGMENT INFORMATION

SEGMENT INFORMATION	9 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	Segment Information Under U.S. GAAP, our operating segments are aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health Care, 4) Fabric & Home Care and 5) Baby, Feminine & Family Care. Our five reportable segments are comprised of: • Beauty : Hair Care (Conditioners, Shampoos, Styling Aids, Treatments); Skin and Personal Care (Antiperspirants and Deodorants, Personal Cleansing, Skin Care); • Grooming : Shave Care (Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Shave Care); Appliances; • Health Care : Oral Care (Toothbrushes, Toothpaste, Other Oral Care); Personal Health Care (Gastrointestinal, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Pain Relief, Other Personal Health Care); • Fabric & Home Care : Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents); Home Care (Air Care, Dish Care, P&G Professional, Surface Care); and • Baby, Feminine & Family Care : Baby Care (Baby Wipes, Taped Diapers and Pants); Feminine Care (Adult Incontinence, Feminine Care); Family Care (Paper Towels, Tissues, Toilet Paper). Our operating segments are comprised of similar product categories. Operating segments that individually accounted for 5% or more of consolidated net sales are as follows: % of Net sales by operating segment (1) Three Months Ended March 31 Nine Months Ended March 31 2022 2021 2022 2021 Fabric Care 23% 23% 23% 22% Home Care 12% 12% 11% 12% Baby Care 11% 11% 10% 10% Skin and Personal Care 9% 9% 10% 10% Family Care 9% 9% 9% 9% Hair Care 8% 9% 9% 9% Oral Care 8% 8% 8% 8% Shave Care 7% 7% 6% 7% Feminine Care 6% 6% 6% 6% Personal Health Care 6% 5% 6% 5% Other 1% 1% 2% 2% Total 100% 100% 100% 100% (1) % of Net sales by operating segment excludes sales held in Corporate. The following is a summary of reportable segment results: Three Months Ended March 31 Nine Months Ended March 31 Net Sales Earnings/(Loss) Before Income Taxes Net Earnings Net Sales Earnings/(Loss) Before Income Taxes Net Earnings Beauty 2022 $ 3,389 $ 792 $ 644 $ 11,279 $ 3,213 $ 2,582 2021 3,316 721 577 10,907 3,145 2,508 Grooming 2022 1,481 353 290 4,979 1,447 1,183 2021 1,438 314 256 4,774 1,277 1,063 Health Care 2022 2,662 625 485 8,314 2,225 1,715 2021 2,356 484 377 7,573 1,993 1,557 Fabric & Home Care 2022 6,699 1,275 969 20,680 4,284 3,297 2021 6,275 1,348 1,027 19,417 4,689 3,626 Baby, Feminine & Family Care 2022 4,935 1,091 836 14,915 3,353 2,576 2021 4,604 1,133 871 14,185 3,803 2,924 Corporate 2022 215 (65) 143 505 (177) 382 2021 120 (123) 141 316 (856) (234) Total Company 2022 $ 19,381 $ 4,071 $ 3,367 $ 60,672 $ 14,345 $ 11,735 2021 18,109 3,877 3,249 57,172 14,051 11,444

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS	9 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Text Block]	Goodwill and Other Intangible Assets Goodwill is allocated by reportable segment as follows: Beauty Grooming Health Care Fabric & Home Care Baby, Feminine & Family Care Total Company Goodwill at June 30, 2021 $ 13,257 $ 13,095 $ 8,046 $ 1,873 $ 4,653 $ 40,924 Acquisitions and divestitures 770 — 1 — — 771 Translation and other (368) (257) (216) (32) (112) (985) Goodwill at March 31, 2022 $ 13,659 $ 12,838 $ 7,831 $ 1,841 $ 4,541 $ 40,710 Goodwill decreased from June 30, 2021 due to currency translation, partially offset by three acquisitions (Farmacy Beauty, Ouai and TULA) in the Beauty reportable segment. Identifiable intangible assets at March 31, 2022 were comprised of: Gross Carrying Amount Accumulated Amortization Intangible assets with determinable lives $ 9,147 $ (6,262) Intangible assets with indefinite lives 21,028 — Total identifiable intangible assets $ 30,175 $ (6,262) Intangible assets with determinable lives consist of brands, patents, technology and customer relationships. The intangible assets with indefinite lives primarily consist of brands. The amortization expense of determinable-lived intangible assets for the three months ended March 31, 2022 and 2021 was $79 and $78, respectively. For the nine months ended March 31, 2022 and 2021, the amortization expense was $230 and $241, respectively. Goodwill and indefinite-lived intangible assets are not amortized but are tested at least annually for impairment by comparing the estimated fair values of our reporting units and underlying indefinite-lived intangible assets to their respective carrying values. We typically use an income method to estimate the fair value of these assets, which is based on forecasts of the expected future cash flows attributable to the respective assets. If the resulting fair value is less than the asset's carrying value, that difference represents an impairment. Our annual impairment testing for goodwill and indefinite-lived intangible assets occurs during the three months ended December 31. The business unit valuations used to test goodwill and intangible assets for impairment depend on a number of significant estimates and assumptions, including macroeconomic conditions, overall category growth rates, competitive activities, cost containment, margin expansion and Company business plans. We believe these estimates and assumptions are reasonable. However, future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill and indefinite-lived intangible assets, including discount rates, tax rates or future cash flow projections, could result in significantly different estimates of the fair values. To the extent changes in such factors result in a failure to achieve the level of projected cash flows initially used to estimate fair value for purposes of establishing or subsequently impairing the carrying amount of goodwill and related intangible assets, we may need to record non-cash impairment charges in the future. Most of our goodwill reporting units are comprised of a combination of legacy and acquired businesses and as a result have fair value cushions that, at a minimum, exceed three times their underlying carrying values. Certain of our reporting units, in particular Shave Care and Appliances, are comprised entirely of acquired businesses and as a result, have historically had fair value cushions that are not as high. The Appliances reporting unit has a fair value that significantly exceeds the underlying carrying value. As previously disclosed, the carrying values of the Shave Care reporting unit and the related Gillette indefinite-lived intangible asset were impaired during the quarter ended June 30, 2019. Based on our impairment testing during the three months ended December 31, 2021, the Shave Care reporting unit fair value exceeded its carrying value by more than 30% and the Gillette indefinite-lived intangible asset fair value exceeded its carrying value by approximately 5%. The most significant assumptions utilized in the determination of the estimated fair values of the Shave Care reporting unit and the Gillette indefinite-lived intangible asset are the net sales and earnings growth rates (including residual growth rates), the discount rate and the royalty rate. The residual growth rates represent the expected rate at which the Shave Care reporting unit and Gillette brand are expected to grow beyond the shorter-term business planning period. The residual growth rate utilized in our fair value estimates is consistent with the reporting unit and brand operating plans and approximates expected long-term category market growth rates. The residual growth rate depends on overall market growth rates, the competitive environment, inflation, relative currency exchange rates and business activities that impact market share. As a result, the residual growth rate could be adversely impacted by a sustained deceleration in category growth, grooming habit changes, devaluation of currencies against the U.S. dollar or an increased competitive environment. The discount rate, which is consistent with a weighted average cost of capital that is likely to be expected by a market participant, is based upon industry required rates of return, including consideration of both debt and equity components of the capital structure. Our discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the equity and debt markets or other country specific factors, such as further devaluation of currencies against the U.S. dollar. Spot rates as of the fair value measurement date are utilized in our fair value estimates for cash flows outside the U.S. The royalty rate used to determine the estimated fair value for the Gillette indefinite-lived intangible asset is driven by historical and estimated future profitability of the underlying Gillette business. The royalty rate may be impacted by significant adverse changes in long-term operating margins. While management has implemented strategies to address these events, changes in operating plans or adverse changes in the business or in the macroeconomic environment in the future could reduce the underlying cash flows used to estimate fair values and could result in a decline in fair value that would trigger future impairment charges of the Shave Care reporting unit's goodwill and Gillette indefinite-lived intangible asset. The duration and severity of the pandemic could also result in future impairment charges for the Shave Care reporting unit goodwill and the Gillette indefinite-lived intangible asset. While we have concluded that no triggering event has occurred during the quarter ended March 31, 2022, the Gillette indefinite-lived intangible asset is most susceptible to future impairment risk. Our assessment of the Gillette indefinite-lived intangible asset assumes the net sales growth rates will continue to recover from the impact of the COVID-19 pandemic during the current fiscal year. There continues to be a high level of uncertainty relating to how the pandemic will evolve, how governments and consumers will react, progress on the distribution of vaccines and whether the pandemic will have a longer-term effect on consumer habits. Accordingly, there continues to be risk related to this key assumption. A more prolonged pandemic recovery period could impact the assumptions utilized in the determination of the estimated fair values of the Shave Care reporting unit and the Gillette indefinite-lived intangible asset that are significant enough to trigger an impairment. Net sales and earnings growth rates could be negatively impacted by reductions or changes in demand for our Shave Care products, which may be caused by, among other things: the Russia-Ukraine War, the temporary inability of consumers to purchase our products due to illness, quarantine or other travel restrictions, or financial hardship, changes in the use and frequency of grooming products, by shifts in demand away from one or more of our higher priced products to lower priced products or by impacts of potential supply chain constraints. In addition, relative global and country/regional macroeconomic factors, including the Russia-Ukraine War, could result in additional and prolonged devaluation of other countries’ currencies relative to the U.S. dollar. Finally, the discount rate utilized in our valuation model could be impacted by changes in the underlying interest rates and risk premiums included in the determination of the cost of capital. As of March 31, 2022, the carrying values of the Shave Care goodwill and the Gillette indefinite-lived intangible asset were $12.5 billion and $14.1 billion, respectively. We performed a sensitivity analysis for the Shave Care reporting unit and the Gillette indefinite-lived intangible asset as part of our annual impairment testing, utilizing reasonably possible changes in the assumptions for the shorter-term and residual growth rates, discount rate and royalty rate to demonstrate the potential impacts to estimated fair values. The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a 25 basis-point decrease in our shorter-term and residual revenue growth rates or a 50 basis-point decrease in our royalty rate, some of which would result in an impairment of the Gillette indefinite-lived intangible asset. Approximate Percent Change in Estimated Fair Value +25 bps Discount Rate -25 bps Growth Rates -50 bps Royalty Rate Shave Care goodwill reporting unit (6)% (6)% N/A Gillette indefinite-lived intangible asset (6)% (6)% (3)% In light of the Russia-Ukraine War, we performed an additional sensitivity analysis for the Shave Care reporting unit and the Gillette indefinite-lived intangible asset for a range of outcomes, including reduced future cash flows and no future cash flows in Ukraine and Russia. Under these scenarios, the Shave Care reporting unit fair value continued to exceed its carrying value by approximately 30% and the Gillette indefinite-lived intangible asset’s fair value exceeded or approximated its carrying value. However, if the impact of the war were to extend beyond its current scope, there could be a triggering event for the Gillette indefinite-lived intangible asset that may cause us to perform an additional impairment assessment for that asset in a future period that may result in an impairment charge.

EARNINGS PER SHARE

EARNINGS PER SHARE	9 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	Earnings Per Share Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble less preferred dividends by the weighted average number of common shares outstanding during the period. Diluted net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble by the diluted weighted average number of common shares outstanding during the period. The diluted shares include the dilutive effect of stock options and other stock-based awards based on the treasury stock method and the assumed conversion of preferred stock. Net earnings per share were calculated as follows: CONSOLIDATED AMOUNTS Three Months Ended March 31 Nine Months Ended March 31 2022 2021 2022 2021 Net earnings $ 3,367 $ 3,249 $ 11,735 $ 11,444 Less: Net earnings/(loss) attributable to noncontrolling interests 12 (20) 45 44 Net earnings attributable to P&G (Diluted) 3,355 3,269 11,690 11,400 Less: Preferred dividends 68 65 208 197 Net earnings attributable to P&G available to common shareholders (Basic) $ 3,287 $ 3,204 $ 11,482 $ 11,203 SHARES IN MILLIONS Basic weighted average common shares outstanding 2,400.5 2,459.1 2,414.0 2,473.7 Add: Effect of dilutive securities Convertible preferred shares (1) 78.9 82.3 79.7 83.1 Stock options and other unvested equity awards (2) 50.8 48.9 50.7 53.6 Diluted weighted average common shares outstanding 2,530.2 2,590.3 2,544.4 2,610.4 NET EARNINGS PER SHARE (3) Basic $ 1.37 $ 1.30 $ 4.76 $ 4.53 Diluted $ 1.33 $ 1.26 $ 4.59 $ 4.37 (1) An overview of preferred shares can be found in our Annual Report on Form 10-K for the year ended June 30, 2021. (2) Excludes 5 million and 12 million for the three months ended March 31, 2022 and 2021, respectively, and 11 million and 8 million for the nine months ended March 31, 2022 and 2021, respectively, of weighted average stock options outstanding because the exercise price of these options was greater than their average market value or their effect was antidilutive. (3) Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

SHARE-BASED COMPENSATION AND PO

SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS	9 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Compensation and Employee Benefit Plans [Text Block]	Share-Based Compensation and Postretirement Benefits The following table provides a summary of our share-based compensation expense and postretirement benefit costs: Three Months Ended March 31 Nine Months Ended March 31 2022 2021 2022 2021 Share-based compensation expense $ 130 $ 144 $ 398 $ 398 Net periodic benefit cost for pension benefits 47 48 143 141 Net periodic benefit credit for other retiree benefits (126) (80) (348) (240)

RISK MANAGEMENT ACTIVITIES AND

RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS	9 Months Ended
	Mar. 31, 2022
Risk Management Activities and Fair Value Measurements [Abstract]
Risk Management And Fair Value [Text Block]	Risk Management Activities and Fair Value Measurements As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. There have been no significant changes in our risk management policies or activities during the nine months ended March 31, 2022. The Company has not changed its valuation techniques used in measuring the fair value of any financial assets and liabilities during the period. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. Also, there was no significant activity within the Level 3 assets and liabilities during the periods presented. There were no significant assets or liabilities that were remeasured at fair value on a non-recurring basis for the nine months ended March 31, 2022. Cash equivalents were $7.0 billion and $9.1 billion as of March 31, 2022 and June 30, 2021, respectively, and are classified as Level 1 within the fair value hierarchy. Other investments had a fair value of $153 and $192 as of March 31, 2022 and June 30, 2021, respectively, including equity securities of $126 and $163 as of March 31, 2022 and June 30, 2021, respectively, and are presented in Other noncurrent assets. Investments are measured at fair value and primarily classified as Level 1 and Level 2 within the fair value hierarchy. Level 1 are based on quoted market prices in active markets for identical assets, and Level 2 are based on quoted market prices for similar instruments. There are no material investment balances classified as Level 3 within the fair value hierarchy or using net asset value as a practical expedient. Unrealized losses on equity securities were $(4) during the three months ended March 31, 2022. Unrealized gains on equity securities were $58 during the three months ended March 31, 2021. Unrealized losses on equity securities were $(36) during the nine months ended March 31, 2022. Unrealized gains on equity securities were $58 during the nine months ended March 31, 2021. These unrealized gains/(losses) are recognized in the Consolidated Statements of Earnings in Other non-operating income/(expense), net. The fair value of long-term debt was $27.8 billion and $28.8 billion as of March 31, 2022 and June 30, 2021, respectively. This includes the current portion of long-term debt instruments ($3.6 billion as of March 31, 2022 and June 30, 2021). Certain long-term debt (debt designated as a fair value hedge) is recorded at fair value. All other long-term debt is recorded at amortized cost but is measured at fair value for disclosure purposes. We consider our debt to be Level 2 in the fair value hierarchy. Fair values are generally estimated based on quoted market prices for identical or similar instruments. Disclosures about Financial Instruments The notional amounts and fair values of financial instruments used in hedging transactions as of March 31, 2022 and June 30, 2021 are as follows: Notional Amount Fair Value Asset Fair Value (Liability) March 31, 2022 June 30, 2021 March 31, 2022 June 30, 2021 March 31, 2022 June 30, 2021 DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS Interest rate contracts $ 5,241 $ 7,415 $ 15 $ 146 $ (182) $ — DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS Foreign currency interest rate contracts $ 8,428 $ 8,484 $ 359 $ 89 $ (10) $ (94) TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS $ 13,669 $ 15,899 $ 374 $ 235 $ (192) $ (94) DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS Foreign currency contracts $ 6,916 $ 5,060 $ 31 $ 20 $ (26) $ (22) TOTAL DERIVATIVES AT FAIR VALUE $ 20,585 $ 20,959 $ 405 $ 255 $ (218) $ (116) The fair value of the interest rate derivative asset/(liability) directly offsets the cumulative amount of the fair value hedging adjustment included in the carrying amount of the underlying debt obligation. The carrying amount of the underlying debt obligation, which includes the unamortized discount or premium and the fair value adjustment, was $5.1 billion and $7.5 billion as of March 31, 2022 and June 30, 2021, respectively. In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The carrying value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency transaction gain or loss on those instruments, was $12.2 billion and $12.0 billion as of March 31, 2022 and June 30, 2021, respectively. The decrease in the notional balance of interest rate contracts was primarily due to the maturity of interest rate swaps that were associated with multiple bonds maturing in the period. The increase in the notional balance of foreign currency contracts not designated as hedging instruments primarily reflects changes in the level of intercompany financing activity during the period. All derivative assets are presented in Prepaid expenses and other current assets or Other noncurrent assets. All derivative liabilities are presented in Accrued and other liabilities or Other noncurrent liabilities. Changes in the fair value of net investment hedges are recognized in the Foreign currency translation component of Other comprehensive income (OCI). All of the Company's derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy. Before tax gains/(losses) on our financial instruments in hedging relationships are categorized as follows: Amount of Gain/(Loss) Recognized in OCI on Derivatives Three Months Ended March 31 Nine Months Ended March 31 2022 2021 2022 2021 DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2) Foreign exchange contracts $ 104 $ 393 $ 530 $ (145) (1) For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $18 and $15 for the three months ended March 31, 2022 and 2021, respectively. The amount of gain excluded from effectiveness testing was $50 and $45 for the nine months ended March 31, 2022 and 2021, respectively. (2) In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain recognized in Accumulated other comprehensive income (AOCI) for such instruments was $237 and $509 for the three months ended March 31, 2022 and 2021, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $804 and $(732) for the nine months ended March 31, 2022 and 2021, respectively. Amount of Gain/(Loss) Recognized in Earnings Three Months Ended March 31 Nine Months Ended March 31 2022 2021 2022 2021 DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS Interest rate contracts $ (216) $ (100) $ (313) $ (95) DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS Foreign currency contracts $ (2) $ (87) $ 28 $ 221 The gain/(loss) on the derivatives in fair value hedging relationships is fully offset by the mark-to-market impact of the related exposure. These are both recognized in the Consolidated Statements of Earnings in Interest expense. The gain/(loss) on derivatives not designated as hedging instruments is substantially offset by the currency mark-to-market of the related exposure. These are both recognized in the Consolidated Statements of Earnings in Selling, general and administrative expense (SG&A).

ACCUMULATED OTHER COMPREHENSIVE

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	9 Months Ended
	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Comprehensive Income (Loss) Note [Text Block]	Accumulated Other Comprehensive Income/(Loss) The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter & Gamble (AOCI), including the reclassifications out of AOCI by component: Investment Securities Post-retirement Benefits Foreign Currency Translation Total AOCI Balance at June 30, 2021 $ 15 $ (2,963) $ (10,796) $ (13,744) OCI before reclassifications (1) 6 812 (683) 135 Amounts reclassified from AOCI into the Consolidated Statements of Earnings (2) 1 156 157 Net current period OCI 7 968 (683) 292 Less: Other comprehensive income/(loss) attributable to non-controlling interests — — (4) (4) Balance at March 31, 2022 $ 22 $ (1,995) $ (11,475) $ (13,448) (1) Net of tax expense of $1, $257 and $314 for gains/losses on investment securities, postretirement benefit items and foreign currency translation, respectively. Income tax effects within foreign currency translation include impacts from items such as net investment hedge transactions. Foreign cumulative translation is not adjusted for income taxes related to permanent investments in international subsidiaries. (2) Net of tax expense of $0, $55 and $0 for gains/losses on investment securities, postretirement benefit items and foreign currency translation, respectively. The below provides additional details on amounts reclassified from AOCI into the Consolidated Statements of Earnings: • Investment securities: amounts reclassified from AOCI into Other non-operating income, net. • Postretirement benefits: amounts reclassified from AOCI into Other non-operating income, net and included in the computation of net periodic postretirement costs.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Commitments and Contingencies Litigation We are subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental, patent and trademark matters, labor and employment matters and tax. While considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows. We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will materially affect our financial position, results of operations or cash flows. Income Tax Uncertainties The Company is present in approximately 70 countries and over 150 taxable jurisdictions and, at any point in time, has 40–50 jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statutes of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2010 and forward. We are generally not able to reliably estimate the ultimate settlement amounts until the close of an audit. Based on information currently available, we anticipate that over the next 12 month period, audit activity could be completed related to uncertain tax positions in multiple jurisdictions for which we have accrued existing liabilities of less than $10, including interest and penalties. Additional information on the Commitments and Contingencies of the Company can be found in our Annual Report on Form 10-K for the year ended June 30, 2021.

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Our operating segments are comprised of similar product categories. Operating segments that individually accounted for 5% or more of consolidated net sales are as follows: % of Net sales by operating segment (1) Three Months Ended March 31 Nine Months Ended March 31 2022 2021 2022 2021 Fabric Care 23% 23% 23% 22% Home Care 12% 12% 11% 12% Baby Care 11% 11% 10% 10% Skin and Personal Care 9% 9% 10% 10% Family Care 9% 9% 9% 9% Hair Care 8% 9% 9% 9% Oral Care 8% 8% 8% 8% Shave Care 7% 7% 6% 7% Feminine Care 6% 6% 6% 6% Personal Health Care 6% 5% 6% 5% Other 1% 1% 2% 2% Total 100% 100% 100% 100% (1) % of Net sales by operating segment excludes sales held in Corporate. The following is a summary of reportable segment results: Three Months Ended March 31 Nine Months Ended March 31 Net Sales Earnings/(Loss) Before Income Taxes Net Earnings Net Sales Earnings/(Loss) Before Income Taxes Net Earnings Beauty 2022 $ 3,389 $ 792 $ 644 $ 11,279 $ 3,213 $ 2,582 2021 3,316 721 577 10,907 3,145 2,508 Grooming 2022 1,481 353 290 4,979 1,447 1,183 2021 1,438 314 256 4,774 1,277 1,063 Health Care 2022 2,662 625 485 8,314 2,225 1,715 2021 2,356 484 377 7,573 1,993 1,557 Fabric & Home Care 2022 6,699 1,275 969 20,680 4,284 3,297 2021 6,275 1,348 1,027 19,417 4,689 3,626 Baby, Feminine & Family Care 2022 4,935 1,091 836 14,915 3,353 2,576 2021 4,604 1,133 871 14,185 3,803 2,924 Corporate 2022 215 (65) 143 505 (177) 382 2021 120 (123) 141 316 (856) (234) Total Company 2022 $ 19,381 $ 4,071 $ 3,367 $ 60,672 $ 14,345 $ 11,735 2021 18,109 3,877 3,249 57,172 14,051 11,444

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	9 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill [Table Text Block]	Goodwill is allocated by reportable segment as follows: Beauty Grooming Health Care Fabric & Home Care Baby, Feminine & Family Care Total Company Goodwill at June 30, 2021 $ 13,257 $ 13,095 $ 8,046 $ 1,873 $ 4,653 $ 40,924 Acquisitions and divestitures 770 — 1 — — 771 Translation and other (368) (257) (216) (32) (112) (985) Goodwill at March 31, 2022 $ 13,659 $ 12,838 $ 7,831 $ 1,841 $ 4,541 $ 40,710
Schedule of Intangible Assets and Goodwill [Table Text Block]	Identifiable intangible assets at March 31, 2022 were comprised of: Gross Carrying Amount Accumulated Amortization Intangible assets with determinable lives $ 9,147 $ (6,262) Intangible assets with indefinite lives 21,028 — Total identifiable intangible assets $ 30,175 $ (6,262)
Schedule of Potential Impacts to Estimated Fair Values [Table Text Block]	The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a 25 basis-point decrease in our shorter-term and residual revenue growth rates or a 50 basis-point decrease in our royalty rate, some of which would result in an impairment of the Gillette indefinite-lived intangible asset. Approximate Percent Change in Estimated Fair Value +25 bps Discount Rate -25 bps Growth Rates -50 bps Royalty Rate Shave Care goodwill reporting unit (6)% (6)% N/A Gillette indefinite-lived intangible asset (6)% (6)% (3)%

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	9 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Net earnings per share were calculated as follows: CONSOLIDATED AMOUNTS Three Months Ended March 31 Nine Months Ended March 31 2022 2021 2022 2021 Net earnings $ 3,367 $ 3,249 $ 11,735 $ 11,444 Less: Net earnings/(loss) attributable to noncontrolling interests 12 (20) 45 44 Net earnings attributable to P&G (Diluted) 3,355 3,269 11,690 11,400 Less: Preferred dividends 68 65 208 197 Net earnings attributable to P&G available to common shareholders (Basic) $ 3,287 $ 3,204 $ 11,482 $ 11,203 SHARES IN MILLIONS Basic weighted average common shares outstanding 2,400.5 2,459.1 2,414.0 2,473.7 Add: Effect of dilutive securities Convertible preferred shares (1) 78.9 82.3 79.7 83.1 Stock options and other unvested equity awards (2) 50.8 48.9 50.7 53.6 Diluted weighted average common shares outstanding 2,530.2 2,590.3 2,544.4 2,610.4 NET EARNINGS PER SHARE (3) Basic $ 1.37 $ 1.30 $ 4.76 $ 4.53 Diluted $ 1.33 $ 1.26 $ 4.59 $ 4.37 (1) An overview of preferred shares can be found in our Annual Report on Form 10-K for the year ended June 30, 2021. (2) Excludes 5 million and 12 million for the three months ended March 31, 2022 and 2021, respectively, and 11 million and 8 million for the nine months ended March 31, 2022 and 2021, respectively, of weighted average stock options outstanding because the exercise price of these options was greater than their average market value or their effect was antidilutive. (3) Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

SHARE-BASED COMPENSATION AND _2

SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Tables)	9 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Compensation and Employee Benefit Plans [Table Text Block]	The following table provides a summary of our share-based compensation expense and postretirement benefit costs: Three Months Ended March 31 Nine Months Ended March 31 2022 2021 2022 2021 Share-based compensation expense $ 130 $ 144 $ 398 $ 398 Net periodic benefit cost for pension benefits 47 48 143 141 Net periodic benefit credit for other retiree benefits (126) (80) (348) (240)

RISK MANAGEMENT ACTIVITIES AN_2

RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Mar. 31, 2022
Risk Management Activities and Fair Value Measurements [Abstract]
Schedule of Derivative Instruments [Table Text Block]	The notional amounts and fair values of financial instruments used in hedging transactions as of March 31, 2022 and June 30, 2021 are as follows: Notional Amount Fair Value Asset Fair Value (Liability) March 31, 2022 June 30, 2021 March 31, 2022 June 30, 2021 March 31, 2022 June 30, 2021 DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS Interest rate contracts $ 5,241 $ 7,415 $ 15 $ 146 $ (182) $ — DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS Foreign currency interest rate contracts $ 8,428 $ 8,484 $ 359 $ 89 $ (10) $ (94) TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS $ 13,669 $ 15,899 $ 374 $ 235 $ (192) $ (94) DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS Foreign currency contracts $ 6,916 $ 5,060 $ 31 $ 20 $ (26) $ (22) TOTAL DERIVATIVES AT FAIR VALUE $ 20,585 $ 20,959 $ 405 $ 255 $ (218) $ (116)
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]	Before tax gains/(losses) on our financial instruments in hedging relationships are categorized as follows: Amount of Gain/(Loss) Recognized in OCI on Derivatives Three Months Ended March 31 Nine Months Ended March 31 2022 2021 2022 2021 DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2) Foreign exchange contracts $ 104 $ 393 $ 530 $ (145) (1) For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $18 and $15 for the three months ended March 31, 2022 and 2021, respectively. The amount of gain excluded from effectiveness testing was $50 and $45 for the nine months ended March 31, 2022 and 2021, respectively. (2) In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain recognized in Accumulated other comprehensive income (AOCI) for such instruments was $237 and $509 for the three months ended March 31, 2022 and 2021, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $804 and $(732) for the nine months ended March 31, 2022 and 2021, respectively.
Derivative Instruments, Gain (Loss) [Table Text Block]	Amount of Gain/(Loss) Recognized in Earnings Three Months Ended March 31 Nine Months Ended March 31 2022 2021 2022 2021 DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS Interest rate contracts $ (216) $ (100) $ (313) $ (95) DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS Foreign currency contracts $ (2) $ (87) $ 28 $ 221

ACCUMULATED OTHER COMPREHENSI_2

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)	9 Months Ended
	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter & Gamble (AOCI), including the reclassifications out of AOCI by component: Investment Securities Post-retirement Benefits Foreign Currency Translation Total AOCI Balance at June 30, 2021 $ 15 $ (2,963) $ (10,796) $ (13,744) OCI before reclassifications (1) 6 812 (683) 135 Amounts reclassified from AOCI into the Consolidated Statements of Earnings (2) 1 156 157 Net current period OCI 7 968 (683) 292 Less: Other comprehensive income/(loss) attributable to non-controlling interests — — (4) (4) Balance at March 31, 2022 $ 22 $ (1,995) $ (11,475) $ (13,448) (1) Net of tax expense of $1, $257 and $314 for gains/losses on investment securities, postretirement benefit items and foreign currency translation, respectively. Income tax effects within foreign currency translation include impacts from items such as net investment hedge transactions. Foreign cumulative translation is not adjusted for income taxes related to permanent investments in international subsidiaries. (2) Net of tax expense of $0, $55 and $0 for gains/losses on investment securities, postretirement benefit items and foreign currency translation, respectively.

SEGMENT INFORMATION - SALES (De

SEGMENT INFORMATION - SALES (Details)		3 Months Ended		9 Months Ended
		Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	100.00%	100.00%	100.00%	100.00%
Fabric Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	23.00%	23.00%	23.00%	22.00%
Home Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	12.00%	12.00%	11.00%	12.00%
Baby Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	11.00%	11.00%	10.00%	10.00%
Skin and Personal Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	9.00%	9.00%	10.00%	10.00%
Family Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	9.00%	9.00%	9.00%	9.00%
Hair Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	8.00%	9.00%	9.00%	9.00%
Oral Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	8.00%	8.00%	8.00%	8.00%
Shave Care
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	7.00%	7.00%	6.00%	7.00%
Feminine Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	6.00%	6.00%	6.00%	6.00%
Personal Health Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	6.00%	5.00%	6.00%	5.00%
All Other [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	1.00%	1.00%	2.00%	2.00%
[1]	% of Net sales by operating segment excludes sales held in Corporate.

SEGMENT INFORMATION (Details)

SEGMENT INFORMATION (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Segment Reporting Information [Line Items]
Net Sales	$ 19,381	$ 18,109	$ 60,672	$ 57,172
Earnings/(Loss) from Continuing Operations Before Income Taxes	4,071	3,877	14,345	14,051
Net Earnings/(Loss) from Continuing Operations	3,367	3,249	11,735	11,444
Beauty
Segment Reporting Information [Line Items]
Net Sales	3,389	3,316	11,279	10,907
Earnings/(Loss) from Continuing Operations Before Income Taxes	792	721	3,213	3,145
Net Earnings/(Loss) from Continuing Operations	644	577	2,582	2,508
Grooming
Segment Reporting Information [Line Items]
Net Sales	1,481	1,438	4,979	4,774
Earnings/(Loss) from Continuing Operations Before Income Taxes	353	314	1,447	1,277
Net Earnings/(Loss) from Continuing Operations	290	256	1,183	1,063
Health Care
Segment Reporting Information [Line Items]
Net Sales	2,662	2,356	8,314	7,573
Earnings/(Loss) from Continuing Operations Before Income Taxes	625	484	2,225	1,993
Net Earnings/(Loss) from Continuing Operations	485	377	1,715	1,557
Fabric and Home Care
Segment Reporting Information [Line Items]
Net Sales	6,699	6,275	20,680	19,417
Earnings/(Loss) from Continuing Operations Before Income Taxes	1,275	1,348	4,284	4,689
Net Earnings/(Loss) from Continuing Operations	969	1,027	3,297	3,626
Baby, Feminine & Family Care
Segment Reporting Information [Line Items]
Net Sales	4,935	4,604	14,915	14,185
Earnings/(Loss) from Continuing Operations Before Income Taxes	1,091	1,133	3,353	3,803
Net Earnings/(Loss) from Continuing Operations	836	871	2,576	2,924
Corporate
Segment Reporting Information [Line Items]
Net Sales	215	120	505	316
Earnings/(Loss) from Continuing Operations Before Income Taxes	(65)	(123)	(177)	(856)
Net Earnings/(Loss) from Continuing Operations	$ 143	$ 141	$ 382	$ (234)

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS - CHANGE IN THE NET CARRYING AMOUNT OF GOODWILL BY GLOBAL BUSINESS UNIT (Details) $ in Millions	9 Months Ended
	Mar. 31, 2022USD ($)
Goodwill [Roll Forward]
Goodwill at June 30, 2021	$ 40,924
Goodwill, Acquisitions and Divestitures	771
Goodwill, Translation and Other	(985)
Goodwill at March 31, 2022	40,710
Beauty
Goodwill [Roll Forward]
Goodwill at June 30, 2021	13,257
Goodwill, Acquisitions and Divestitures	770
Goodwill, Translation and Other	(368)
Goodwill at March 31, 2022	13,659
Grooming
Goodwill [Roll Forward]
Goodwill at June 30, 2021	13,095
Goodwill, Acquisitions and Divestitures	0
Goodwill, Translation and Other	(257)
Goodwill at March 31, 2022	12,838
Health Care
Goodwill [Roll Forward]
Goodwill at June 30, 2021	8,046
Goodwill, Acquisitions and Divestitures	1
Goodwill, Translation and Other	(216)
Goodwill at March 31, 2022	7,831
Fabric & Home Care
Goodwill [Roll Forward]
Goodwill at June 30, 2021	1,873
Goodwill, Acquisitions and Divestitures	0
Goodwill, Translation and Other	(32)
Goodwill at March 31, 2022	1,841
Baby, Feminine & Family Care
Goodwill [Roll Forward]
Goodwill at June 30, 2021	4,653
Goodwill, Acquisitions and Divestitures	0
Goodwill, Translation and Other	(112)
Goodwill at March 31, 2022	$ 4,541

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS - IDENTIFIABLE INTANGIBLE ASSETS (Details) $ in Millions	Mar. 31, 2022USD ($)
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 30,175
Accumulated Amortization	(6,262)
Intangible Assets with Indefinite Lives
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	21,028
Accumulated Amortization	0
Intangible Assets with Determinable Lives
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	9,147
Accumulated Amortization	$ (6,262)

GOODWILL AND OTHER INTANGIBLE_5

GOODWILL AND OTHER INTANGIBLE ASSETS - FAIR VALUE SENSITIVITY (Details)	Mar. 31, 2022
Intangible Assets with Indefinite Lives | Gillette | 25 bps Decrease Long-Term Growth [Member]
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]
Percent Change in Estimated Fair Value	(6.00%)
Intangible Assets with Indefinite Lives | Gillette | 25 bps Increase Discount Rate [Member]
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]
Percent Change in Estimated Fair Value	(6.00%)
Intangible Assets with Indefinite Lives | Gillette | 50 bps Decrease Long-Term Royalty [Member]
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]
Percent Change in Estimated Fair Value	(3.00%)
Goodwill | Shave Care | 25 bps Decrease Long-Term Growth [Member]
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]
Percent Change in Estimated Fair Value	(6.00%)
Goodwill | Shave Care | 25 bps Increase Discount Rate [Member]
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]
Percent Change in Estimated Fair Value	(6.00%)

GOODWILL AND OTHER INTANGIBLE_6

GOODWILL AND OTHER INTANGIBLE ASSETS - ADDITIONAL INFORMATION (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Jun. 30, 2021
Other Significant Noncash Transactions [Line Items]
Amortization of Intangible Assets	$ 79	$ 78	$ 230	$ 241
Goodwill	40,710		40,710			$ 40,924
Shave Care
Other Significant Noncash Transactions [Line Items]
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount					30.00%
Goodwill	$ 12,500		$ 12,500
Shave Care | Goodwill | Potential Impacts to Carrying Value
Other Significant Noncash Transactions [Line Items]
Carrying Value Sensitivity	30.00%		30.00%
Gillette
Other Significant Noncash Transactions [Line Items]
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount					5.00%
Intangible Assets with Indefinite Lives | Gillette
Other Significant Noncash Transactions [Line Items]
Intangible Assets, Net (Including Goodwill)	$ 14,100		$ 14,100

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		3 Months Ended		9 Months Ended
		Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Earnings Per Share Reconciliation [Abstract]
Net Earnings		$ 3,367	$ 3,249	$ 11,735	$ 11,444
Net Income (Loss) Attributable to Noncontrolling Interest		12	(20)	45	44
Net Earnings/(Loss) Attributable to P&G (Diluted)		3,355	3,269	11,690	11,400
Dividends, Preferred Stock		68	65	208	197
Net Earnings/(Loss) Attributable to P&G Available to Common Shareholders (Basic)		$ 3,287	$ 3,204	$ 11,482	$ 11,203
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic Weighted Average Common Shares Outstanding		2,400.5	2,459.1	2,414	2,473.7
Effect of Dilutive Securities
Conversion of Preferred Shares	[1]	78.9	82.3	79.7	83.1
Exercise of Stock Options and Other Unvested Equity Awards	[2]	50.8	48.9	50.7	53.6
Diluted Weighted Average Common Shares Outstanding		2,530.2	2,590.3	2,544.4	2,610.4
Basic Net Earnings/(Loss) Per Common Share	[3],[4]	$ 1.37	$ 1.30	$ 4.76	$ 4.53
Diluted Net Earnings/(Loss) Per Common Share	[3],[4]	$ 1.33	$ 1.26	$ 4.59	$ 4.37
[1]	An overview of preferred shares can be found in our Annual Report on Form 10-K for the year ended June 30, 2021.
[2]	Excludes 5 million and 12 million for the three months ended March 31, 2022 and 2021, respectively, and 11 million and 8 million for the nine months ended March 31, 2022 and 2021, respectively, of weighted average stock options outstanding because the exercise price of these options was greater than their average market value or their effect was antidilutive.
[3]	Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
[4]	Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

EARNINGS PER SHARE - ANTIDILUTI

EARNINGS PER SHARE - ANTIDILUTIVE SECURITIES (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Employee Stock Option
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	5	12	11	8

SHARE-BASED COMPENSATION AND _3

SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Abstract]
Share-based Payment Arrangement, Expense	$ 130	$ 144	$ 398	$ 398
Pension Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Defined Benefit Plan, Net Periodic Benefit Cost (Credit)	47	48	143	141
Other Postretirement Benefit Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Defined Benefit Plan, Net Periodic Benefit Cost (Credit)	$ (126)	$ (80)	$ (348)	$ (240)

RISK MANAGEMENT ACTIVITIES AN_3

RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - SCHEDULE OF DERIVATIVE INSTRUMENTS (Details) - USD ($) $ in Millions	Mar. 31, 2022	Jun. 30, 2021
Derivative [Line Items]
Derivative, Notional Amount	$ 20,585	$ 20,959
Derivative Asset	405	255
Derivative Liability	(218)	(116)
Derivatives in Fair Value Hedging Relationships | Interest Rate Contracts
Derivative [Line Items]
Derivative, Notional Amount	5,241	7,415
Derivative Asset	15	146
Derivative Liability	(182)	0
Derivatives in Net Investment Hedging Relationships | Foreign Exchange Contract
Derivative [Line Items]
Derivative, Notional Amount	8,428	8,484
Derivative Asset	359	89
Derivative Liability	(10)	(94)
Designated as Hedging Instrument
Derivative [Line Items]
Derivative, Notional Amount	13,669	15,899
Derivative Asset	374	235
Derivative Liability	(192)	(94)
Not Designated as Hedging Instrument | Foreign Exchange Contract
Derivative [Line Items]
Derivative, Notional Amount	6,916	5,060
Derivative Asset	31	20
Derivative Liability	$ (26)	$ (22)

RISK MANAGEMENT ACTIVITIES AN_4

RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - DERIVATIVE INSTRUMENTS, EFFECT ON OTHER COMPREHENSIVE INCOME (LOSS) (Details) - Derivatives in Net Investment Hedging Relationships - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net		$ 18	$ 15	$ 50	$ 45
Accumulated Other Comprehensive Income, Gain (Loss)		$ 237	$ 509	$ 804	$ (732)
Foreign Exchange Contract
Derivative Instruments, Gain (Loss) [Line Items]
Description of Location of Gain (Loss) on Net Investment Hedges in Financial Statements	[1],[2]	104	393	530	(145)
[1]	For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $18 and $15 for the three months ended March 31, 2022 and 2021, respectively. The amount of gain excluded from effectiveness testing was $50 and $45 for the nine months ended March 31, 2022 and 2021, respectively.
[2]	In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain recognized in Accumulated other comprehensive income (AOCI) for such instruments was $237 and $509 for the three months ended March 31, 2022 and 2021, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $804 and $(732) for the nine months ended March 31, 2022 and 2021, respectively.

RISK MANAGEMENT ACTIVITIES AN_5

RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - DERIVATIVE INSTRUMENTS GAIN (LOSS) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Not Designated as Hedging Instrument | Foreign Currency Contract
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	$ (2)	$ (87)	$ 28	$ 221
Derivatives in Fair Value Hedging Relationships | Interest Rate Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	$ (216)	$ (100)	$ (313)	$ (95)

RISK MANAGEMENT ACTIVITIES AN_6

RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - ADDITIONAL INFORMATION (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents, at Carrying Value	$ 7,000		$ 7,000		$ 9,100
Equity Securities, FV-NI	126		126		163
Equity Securities, FV-NI, Unrealized Gain (Loss)	(4)	$ 58	(36)	$ 58
Derivatives in Fair Value Hedging Relationships | Underlying, Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Underlying Debt Obligation, Carrying Amt	5,100		5,100		7,500
Derivatives in Net Investment Hedging Relationships | Underlying, Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Underlying Debt Obligation, Carrying Amt	12,200		12,200		12,000
Long-term Debt [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term Debt, Fair Value	27,800		27,800		28,800
Long Term Debt, Current Maturities Measured at Fair Value	3,600		3,600		3,600
Other Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	$ 153		$ 153		$ 192

ACCUMULATED OTHER COMPREHENSI_3

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - CHANGES IN AOCI AND RECLASSIFICATION OUT OF AOCI (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021
Accumulated Other Comprehensive Income/(Loss)		$ (13,448)		$ (13,448)		$ (13,744)
OCI before Reclassifications	[1]			135
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	[2]			157
Other Comprehensive Income (Loss), Net of Tax		112	$ (399)	292	$ 682
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest				(4)
Accumulated Other Comprehensive Income (Loss), Derivative Qualifying as Hedge, Excluded Component, Including Portion Attributable to Noncontrolling Interest [Member]
Other Comprehensive Income (Loss) before Reclassifications, Tax	[1]			314
Reclassification from AOCI, Current Period, Tax	[2]			0
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income/(Loss)		22		22		15
OCI before Reclassifications	[1]			6
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	[2]			1
Other Comprehensive Income (Loss), Net of Tax				7
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest				0
Other Comprehensive Income (Loss) before Reclassifications, Tax	[1]			1
Reclassification from AOCI, Current Period, Tax	[2]			0
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest
Accumulated Other Comprehensive Income/(Loss)		(1,995)		(1,995)		(2,963)
OCI before Reclassifications	[1]			812
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	[2]			156
Other Comprehensive Income (Loss), Net of Tax				968
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest				0
Other Comprehensive Income (Loss) before Reclassifications, Tax	[1]			257
Reclassification from AOCI, Current Period, Tax	[2]			55
Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income/(Loss)		$ (11,475)		(11,475)		$ (10,796)
OCI before Reclassifications	[1]			(683)
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	[2]
Other Comprehensive Income (Loss), Net of Tax				(683)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest				$ (4)
[1]	Net of tax expense of $1, $257 and $314 for gains/losses on investment securities, postretirement benefit items and foreign currency translation, respectively. Income tax effects within foreign currency translation include impacts from items such as net investment hedge transactions. Foreign cumulative translation is not adjusted for income taxes related to permanent investments in international subsidiaries.
[2]	Net of tax expense of $0, $55 and $0 for gains/losses on investment securities, postretirement benefit items and foreign currency translation, respectively.

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - ADDITIONAL INFORMATION (Details) $ in Millions	9 Months Ended
	Mar. 31, 2022USD ($)audittaxable_jurisdictioncountries
Loss Contingencies [Line Items]
Number of Countries With On The Ground Operations | countries	70
Number of Taxable Jurisdictions | taxable_jurisdiction	150
Tax Adjustments, Settlements, and Unusual Provisions | $	$ 10
Minimum
Loss Contingencies [Line Items]
Number of Audits Typically Underway	40
Maximum
Loss Contingencies [Line Items]
Number of Audits Typically Underway	50